Concord Biotech Limited (NSE:CONCORDBIO)

Paramount Global Revenue

Concord Biotech had revenue of 2.04B INR in the quarter ending June 30, 2025, a decrease of -5.47%. This brings the company's revenue in the last twelve months to 11.88B, up 14.49% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.

• Revenue (ttm): 11.88B
• Revenue Growth: +14.49%
• P/S Ratio: 14.51
• Revenue / Employee: 8.63M
• Employees: 1,377
• Market Cap: 172.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	12.00B	1.83B	18.01%
Mar 31, 2024	10.17B	1.64B	19.20%
Mar 31, 2023	8.53B	1.40B	19.67%
Mar 31, 2022	7.13B	959.91M	15.56%
Mar 31, 2021	6.17B	1.05B	20.42%